What are the side effects of buspirone (anxiolytic medication)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Buspirone Side Effects

Buspirone's most common side effects include dizziness (12%), nausea (8%), headache (6%), nervousness (5%), and lightheadedness (3%), with approximately 10% of patients discontinuing treatment due to adverse events, primarily CNS disturbances. 1

Most Common Side Effects (≥1% incidence)

The FDA-approved labeling identifies the following side effects occurring at higher rates than placebo in controlled trials 1:

Central Nervous System Effects

  • Dizziness (12%) - most frequent side effect 1
  • Drowsiness (10%) 1
  • Nervousness (5%) 1
  • Insomnia (3%) 1
  • Lightheadedness (3%) 1
  • Decreased concentration (2%) 1
  • Excitement (2%) 1
  • Anger/hostility (2%) 1
  • Confusion (2%) 1
  • Depression (2%) 1

Gastrointestinal Effects

  • Nausea (8%) - second most common side effect 1
  • Dry mouth (3%) 1
  • Abdominal/gastric distress (2%) 1
  • Diarrhea (2%) 1
  • Constipation (1%) 1
  • Vomiting (1%) 1

Other Common Effects

  • Headache (6%) 1
  • Fatigue (4%) 1
  • Weakness (2%) 1
  • Tachycardia/palpitations (1%) 1
  • Blurred vision (2%) 1

Discontinuation Rates

Approximately 10% of patients discontinued buspirone in premarketing trials due to adverse events 1. The primary reasons for discontinuation were:

  • CNS disturbances (3.4%): primarily dizziness, insomnia, nervousness, drowsiness, and lightheadedness 1
  • GI disturbances (1.2%): primarily nausea 1
  • Miscellaneous (1.1%): primarily headache and fatigue 1
  • Multiple complaints (3.4%) 1

Less Common but Clinically Important Side Effects

Cardiovascular (Infrequent to Rare)

  • Syncope, hypotension, hypertension (infrequent) 1
  • Cerebrovascular accident, congestive heart failure, myocardial infarction, cardiomyopathy, bradycardia (rare) 1

Neurological/Psychiatric (Infrequent to Rare)

  • Dream disturbances (frequent) 1
  • Depersonalization, dysphoria, euphoria, akathisia, hallucinations, involuntary movements (infrequent) 1
  • Suicidal ideation and seizures (infrequent) 1
  • Stupor, slurred speech, psychosis (rare) 1

Other Systems

  • Sexual dysfunction: decreased or increased libido (infrequent), delayed ejaculation and impotence (rare) 1
  • Hepatic: increases in aminotransferases (SGOT, SGPT) (infrequent) 1
  • Hematologic: eosinophilia, leukopenia, thrombocytopenia (rare) 1

Postmarketing Reports

Additional adverse events reported since market introduction include 1:

  • Allergic reactions (including urticaria) and angioedema
  • Extrapyramidal symptoms: cogwheel rigidity, dystonic reactions, dyskinesias (acute and tardive), parkinsonism, akathisia, restless leg syndrome
  • Serotonin syndrome
  • Ataxias, vertigo
  • Transient difficulty with recall
  • Urinary retention
  • Visual changes (including tunnel vision)

Important Clinical Considerations

Comparison to Benzodiazepines

Unlike benzodiazepines, buspirone 2, 3, 4:

  • Lacks anticonvulsant and muscle-relaxant properties
  • Causes minimal sedation
  • Does not impair psychomotor function when combined with alcohol
  • Has no reported abuse, dependence, or withdrawal symptoms
  • Does not potentiate sedative-hypnotic drugs

Onset and Tolerability

  • Buspirone may take 2-4 weeks to become effective for anxiety management 5
  • The frequency of adverse effects is generally low 2
  • Most side effects are mild and transient 2, 4

Common Pitfalls

  • Previous benzodiazepine exposure: Patients with chronic benzodiazepine use may experience reduced efficacy and higher dropout rates with buspirone, particularly if unable to complete adequate washout periods 6
  • Nausea and giddiness are the primary side effects leading to early discontinuation 6
  • Starting doses should be low (5 mg twice daily) and titrated gradually to minimize side effects 5

References

Research

Azaspirodecanediones in generalized anxiety disorder: buspirone.

Journal of affective disorders, 1987

Guideline

Buspirone Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.